Search Results - RERO DOC

Vascular response to everolimus- and biolimus-eluting coronary stents versus everolimus-eluting bioresorbable scaffolds – an optical coherence tomography substudy of the EVERBIO II trial

Kallinikou, Zacharenia ; Arroyo, Diego ; Togni, Mario ; Lehmann, Sonja ; Corpataux, Noé ; Cook, Malica ; Müller, Olivier ; Baeriswyl, Gérard ; Stauffer, Jean-Christophe ; Goy, Jean-Jacques ; Puricel, Serban ; Cook, Stéphane

In: Swiss Medical Weekly, 2016, p. -

QUESTIONS UNDER STUDY: Head-to-head optical coherence tomography (OCT) data comparing metallic stents with bioresorbable vascular scaffolds (BVS) are lacking. This study assessed vascular healing at 9-month follow-up after implantation of everolimus- and biolimus-eluting stents (EES BES) and everolimus-eluting BVS.METHODS: OCT was performed in 74 patients enrolled in the EVERBIO II (NCT01711931)...

OPEN IN
SONAR

A randomized comparison of platelet reactivity in patients after treatment with various commercial clopidogrel preparations: The CLO-CLO trial = Étude randomisée comparant la réactivité plaquettaire des patients traités par diverses préparations commerciales de clopidogrel. Étude CLO-CLO

Oberhänsli, Markus ; Lehner, Cédric ; Puricel, Serban ; Lehmann, Sonja ; Togni, Mario ; Stauffer, Jean-Christophe ; Baeriswyl, Gérard ; Goy, Jean-Jacques ; Cook, Stéphane

In: Archives of Cardiovascular Diseases, 2012, vol. 105, no. 11, p. 587–592

BackgroundThe salt linked to the clopidogrel molecule in generic preparations is suspected to affect its clinical efficacy. There is a lack of information about inhibition of platelet reactivity by generic preparations.AimsTo compare the effect of original clopidogrel (clopidogrel bisulphate [Plavix®]), generic clopidogrel preparations (clopidogrel hydrochloride...

Refine my results

Document type

Institution

Specific Collection

Language

Author